Governance & Compliance

How a consulting practice earns the right to speak on behalf of clinicians.

Healthcare marketing is a regulated act, not a creative one. This page is maintained by the practice to answer common governance and data-handling questions from Managing Directors and Chiefs of Surgery.

✓ CONTROL

NMC-Aligned Messaging

Every asset — landing page, ad copy, physician bio, patient story — is reviewed against the National Medical Commission's professional conduct regulations before it goes live. No superlative claims, no comparative advertising, no outcome guarantees.

✓ CONTROL

NABH-Sensitive Clinical Claims

Where a hospital holds NABH accreditation, claims are anchored to the audited scope. Where accreditation is pending or partial, we say so — explicitly.

✓ CONTROL

DPDP Act 2023 & HIPAA-Grade Data Handling

Patient enquiries are collected under lawful basis with explicit purpose limitation. PII is minimised at collection, encrypted at rest and in transit, and never used for retargeting or shared with third parties outside the engagement.

✓ CONTROL

DCGI Advertising Guidelines

For programs involving drugs, devices or clinical trials, all copy is passed through the Drugs Controller General of India's advertising boundary before deployment.

✓ CONTROL

Clinician-Reviewed Editorial

Long-form content is co-authored with the treating clinician and reviewed by an empanelled medical editor. We publish under the surgeon's byline, with their consent, or not at all.

✓ CONTROL

Attribution Under Audit

ROAS, admission counts and CAC figures are reconciled monthly against the Hospital Information System — not self-reported by us. Every campaign has an auditable trail from ad-view to billed IP.

Practice Commitments

Five briefs we will always decline.

A hospital's brand is a public-health asset. These are the boundaries we hold, in writing, at engagement.

  • We will decline any brief that requires an outcome guarantee.
  • We will decline any brief that requires disparaging a competing hospital.
  • We will decline any brief that misrepresents the clinical scope of a facility.
  • We will disclose any commercial relationship with a device or pharma partner in writing.
  • We will pause a live campaign within 24 hours if a compliance question is raised.

Note

This page describes the operating posture of Rukman Digital Venture as a consulting practice. It is not a substitute for the compliance frameworks maintained by the partnering hospital, nor a certification issued by any regulatory body. Where a specific control matters to your board, we will document it in the engagement letter.

Request our engagement letter and DPA template.

Request Documents →